GLAS · Glass House Brands Inc.
$9.79
+0.27 (+2.84%)
At close · Aug 21
Market Cap
$922.63M
Shares
94.24M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$181.98M
-9.4%
FY2025
Net Income
-$29.66M
-5814.6%
FY2025
Gross Margin
42.29%
-6.2pp
FY2025
Operating Margin
-9.08%
-11.9pp
FY2025
Diluted EPS
-$0.55
-161.9%
FY2025
Operating Cash Flow
$11.45M
-59.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| $181.98M | $200.9M | $160.84M | $84.87M | $63.19M | $48.26M | |
| — | $0 | $0 | $0 | $0 | — | |
| $105.02M | $103.51M | $79.87M | $64.16M | $47.39M | $29.52M | |
| $76.96M | $97.39M | $80.97M | $20.71M | $15.8M | $18.74M | |
| 42.29% | 48.48% | 50.34% | 24.4% | 25% | 38.83% | |
| $2.67M | $2.42M | $2.84M | $3.43M | $3.53M | $1.49M | |
| $64.1M | $60.13M | $52.91M | $45.57M | $33.78M | $18.64M | |
| $700K | $700K | $1.1M | $978K | $170.17K | $188.33K | |
| $15M | $14.3M | $13.5M | $11.32M | $4.6M | $2.39M | |
| $93.49M | $91.66M | $130.5M | $77.11M | $51.97M | $24.74M | |
| -$16.53M | $5.74M | -$49.53M | -$56.39M | -$36.18M | -$6M | |
| -9.08% | 2.86% | -30.79% | -66.44% | -57.25% | -12.44% | |
| -$1.53M | $20.04M | -$36.03M | -$45.07M | -$31.58M | -$3.62M | |
| $7.06M | $9.18M | $9.82M | $7.61M | $2.74M | $2.18M | |
| -$485K | $5.48M | -$38.59M | $19.04M | -$5.11M | — | |
| $84K | $14K | -$2.1M | -$2.01M | -$1.09M | -$2.13M | |
| — | — | — | -$2.01M | -$1.09M | -$2.13M | |
| -$17.02M | $11.22M | -$88.12M | -$37.35M | -$41.29M | -$10.24M | |
| $11.93M | $10.5M | $9.94M | -$4.39M | $2.01M | $6.42M | |
| -$29.66M | $519K | -$98.27M | -$32.9M | -$43.1M | -$16.66M | |
| -16.3% | 0.26% | -61.1% | -38.77% | -68.21% | -34.52% | |
| $707K | $202K | $209K | -$61.68K | -$197.77K | $0 | |
| -$45.06M | -$15.44M | -$116.71M | -$53.15M | -$44.9M | — | |
| USD/shares | -$0.55 | -$0.21 | -$1.62 | -$0.83 | -$1.11 | -$0.78 |
| USD/shares | -$0.55 | -$0.21 | -$1.62 | -$0.83 | -$1.11 | -$0.78 |
| shares | 81.94M | 75.23M | 72.03M | 64.18M | 40.28M | 21.27M |
| shares | 81.94M | 75.23M | 72.03M | 64.18M | 40.28M | 21.27M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.97×
EV/EBIT
—
Peer median 16.50×
P/E (TTM)
—
Peer median 14.94×
Peer medians compare against the 51 similar-size Drug Manufacturers - Specialty & Generic companies (of 104 listed).